Improved outcomes after radiotherapy for prostate cancer: Anticoagulation, antiplatelet therapy, and platelet count as key factors in disease progression

BACKGROUND: Several studies have suggested that antiplatelet (AP) or anticoagulant (AC) therapy may improve outcome in men with prostate cancer. We evaluated the effects of AP/AC therapy and tested the hypothesis that platelet count may also be associated with outcomes. METHODS: A total of 482 patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutiontov, Stanley I., Choe, Kevin S., Miller, Jonathan L., Liauw, Stanley L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333841/
https://www.ncbi.nlm.nih.gov/pubmed/32400122
http://dx.doi.org/10.1002/cam4.3087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333841/
https://www.ncbi.nlm.nih.gov/pubmed/32400122
http://dx.doi.org/10.1002/cam4.3087

Ejemplares similares